Article de revue
Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh
A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make them more attractive for use against endemic and epidemic cholera. The researchers conducted an efficacy trial of a single dose of the killed oral cholera vaccine Shanchol, which is currently given in a two-dose schedule, in an urban area in which cholera is highly endemic.
Auteurs
- John D. Clemens
- Yasmin A. Begum
- Arifuzzaman Khan
- Afroza Akter
- M.Phil
- Muhammad Asaduzzaman
- Iqbal A. Khan
- M.Med
- Amit Saha
- Ashraful I. Khan
- Fahima Chowdhury
- Mohammad Ali
- Thomas F. Wierzba
- Taufiqur R. Bhuiyan
- Farhana Khanam
- Mohiul I. Chowdhury
- Ajit P. Singh
- Sachin N Desai
- Alejandro Cravioto
- Alamgir Kabir
- Nirod C Saha
- Ashraf U. Siddik
- Deok R. Kim
- Young A. You
- Shah A. Siddique
- Anisur Rahman
- Atique I. Chowdhury
- Taufiqul Islam
- Firdausi Qadri
Langues
- Anglais
Année de publication
2016
Journal
NJEM
Volume
374
Numéro
18
Type
Article de revue
Catégories
- Vaccins et dispositifs d'administration
Maladies
- Choléra
Pays
- Bangladesh
Mots-clés
- Essais de vaccin
Régions de l'OMS
- Région de l'Asie du Sud-Est
